NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 -0.01 (-0.73%)
As of: Sep 30, 2026 · 9:57 AM EDT

NovaBridge Biosciences (NBP) FCF Margin (2020)

Updated

NovaBridge Biosciences (NBP) posted FCF Margin of -28963.18% for FY2023, down 18813.38 percentage points from -10149.80% in FY2022.

Analysis

NovaBridge Biosciences (NBP) FCF Margin (2020) Analysis & Trends

Since FY2017, NovaBridge Biosciences has reported FCF Margin for 7 years.

  • Annual FCF Margin has declined for three consecutive years, with a five-year change of -28468.03 percentage points (FY2018 to FY2023).
  • The FY2023 figure stands as the lowest annual FCF Margin in data going back to FY2017.
  • Business Quant data shows NBP's FCF Margin at -10149.80% in FY2022 (-9091.22 pp), -1058.58% in FY2021 (-1087.20 pp), 28.62% in FY2020 (+2881.26 pp) and -2852.63% in FY2019 (-2357.49 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 66.51%
API Access

NovaBridge Biosciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NBP&period=max&api_key=YOUR_API_KEY